Suchergebnisse - "Goyal, Srashti"

PubPharm (8)

1

Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function

enthalten in: European journal of pharmacology | 2023

von Dasari, D. | Goyal, S. | Penmetsa, A. | +2

2

Downregulation of nesfatin-1 expression in acute kidney injury in vivo in wistar rats and in vitro in cultured cells

enthalten in: Life sciences | 2022

von Goyal, S. | Dhar, A.

3

Miniaturized and IoT Enabled Continuous-Flow-Based Microfluidic PCR Device for DNA Amplification

enthalten in: IEEE transactions on nanobioscience | 2022

von Kulkarni, M. | Goyal, S. | Dhar, A. | +2

4

Novel therapeutics for the treatment of hypertension and its associated complications : peptide- and nonpeptide-based strategies

enthalten in: Hypertension research : official journal of the Japanese Society of Hypertension | 2021

von Ghatage, T. | Goyal, S. | Dhar, A. | +1

5

High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats

enthalten in: Scientific reports | 2021

von Udumula, M. | Mangali, S. | Kalra, J. | +7

ErratumIn: Sci Rep. 2021 Aug 19;11(1):17152. - PMID 34413426

6

COVID-19 : Analytic results for a modified SEIR model and comparison of different intervention strategies

enthalten in: Chaos, solitons, and fractals | 2021

von Das, A. | Dhar, A. | Goyal, S. | +2

7

PKR inhibitor imoxin prevents hypertension, endothelial dysfunction and cardiac and vascular remodelling in L-NAME-treated rats

enthalten in: Life sciences | 2020

von Kalra, J. | Dasari, D. | Bhat, A. | +4

8

SGLT1 inhibition boon or bane for diabetes-associated cardiomyopathy

enthalten in: Fundamental & clinical pharmacology | 2020

von Kalra, J. | Mangali, S. | Dasari, D. | +5

1
[1]